The NCAA College Basketball tournament may be must-see TV but here mobile health apps and devices are in the throes of competition and the stakes are high. Adherence, remote monitoring, engagement, improved outcomes, reduced healthcare costs. So begins our mini tournament of mobile health apps.
Mobile Mim by Mim Software (FDA cleared) vs Smartphone Breathalyzer by Breathometer
Mobile Mim, an app designed to share images from radiation oncology, radiology, nuclear medicine, neuroimaging, and cardiac imaging, was so ahead of the curve that it was the first medical app to be included when the iTunes app store opened in 2008, but later had to removed it after coming under pressure from the US Food and Drug Administration. Still, it got 510(k) clearance from the regulator in 2011. The medical app is intended to enhance physicians’ access to scans to help them consult with peers on challenging cases, reduce image distribution delays, share images with referring physicians, partner institutions, and patients.
Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
Crowdfunded by Indigogo, the Breathometer’s smartphone breathalyzer is designed for users to make more informed safer decisions by being able to quantify their blood alcohol level themselves. Although still in Beta testing, it’s expected to be launched this summer. Real time blood alcohol levels could make a big difference to the number of drunk driving accidents. But without any studies proving its effectiveness I would be hard pressed to favor an app I would be basing a decision that could affect not just my life but others around me.
Winner: Mobile Mim
Why? Mobile Mim makes sharing patient X-rays and scans more efficient. It enhances patient and physician interaction and through its cloud-backed platform provides easier access to patient studies.
